The company processes soybeans to produce crude oil for edible oil refiners and high-protein de-oiled cake used as a primary ingredient in animal and poultry feed.
The company operates in a highly commoditized industry with razor-thin net margins of 0.5%, indicating no pricing power. While they produce high-protein variants, the lack of durable ROIC above the cost of capital and the negative cash conversion cycle suggest they are price-takers in a fragmented market.
Management has prioritized aggressive capacity expansion and an IPO to fund working capital, yet this growth has resulted in negative cash conversion and declining EPS despite massive revenue increases.
The company's aggressive pursuit of revenue growth without profit proved fatal as the 0.5% net margins were entirely consumed by rising interest costs and working capital inefficiencies. The massive inventory build-up, which previously signaled a 65% drop in turnover, eventually led to significant write-downs, while the negative cash conversion cycle forced the company into a debt spiral to fund basic operations. As EPS continued its downward trajectory despite higher sales, the market finally realized that the business was merely a high-volume, low-value pass-through entity for commodities, leading to a permanent re-rating and capital impairment.
RichFakir rates Yashhtej Industries (India) Ltd's business quality as poor — 18/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Yashhtej Industries (India) Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Yashhtej Industries (India) Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Yashhtej Industries (India) Ltd's fair value is about ₹5 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →